TIDMSLN

RNS Number : 1711D

Silence Therapeutics PLC

05 October 2018

 
 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
 
 1. Identity of the issuer or the underlying                                     Silence Therapeutics 
  issuer 
  of existing shares to which voting rights 
  are 
  attached: (ii) 
                                                                            ------------------------- 
 2 Reason for the notification (please tick the appropriate box or boxes): 
 An acquisition or disposal of voting rights                                              X 
------------------------------------------------------------------------------  --------------------- 
 An acquisition or disposal of qualifying financial instruments 
  which may result in the acquisition of shares already issued to 
  which voting rights are attached 
------------------------------------------------------------------------------  --------------------- 
 An acquisition or disposal of instruments with similar economic 
  effect to qualifying financial instruments 
------------------------------------------------------------------------------  --------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------  --------------------- 
 Other (please 
  specify): 
-------------------------------------------------------------------------  ---  --------------------- 
 3. Full name of person(s) subject                                                      Ali Mortazavi 
  to the 
  notification obligation: (iii) 
                                                                            ------------------------- 
 4. Full name of shareholder(s)                                                         Ali Mortazavi 
  (if different from 3.):(iv) 
                                                                            ------------------------- 
 5. Date of the transaction and date                                                  04 October 2018 
  on 
  which the threshold is crossed 
  or 
  reached: (v) 
                                                                            ------------------------- 
 6. Date on which issuer notified:                                                    05 October 2018 
                                                                            ------------------------- 
 7. Threshold(s) that is/are crossed 
  or 
  reached: (vi, vii)                                                                           3%, 4% 
                                                                            ------------------------- 
 
 
 
 8. Notified details: 
 A: Voting rights attached to shares (viii, ix) 
 Class/type     Situation previous                Resulting situation after the triggering 
 of              to the triggering                 transaction 
 shares          transaction 
 
 if possible 
 using 
 the ISIN 
 CODE 
               --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number          Number of voting         % of voting rights 
                of                of               of shares       rights                   (x) 
                Shares            Voting 
                                  Rights 
               ---------------  ---------------  --------------  -----------------------  ---------------------------- 
                                                  Direct          Direct      Indirect     Direct        Indirect 
                                                                   (xi)        (xii) 
                   -----------    -----------    --------------  ----------  -----------  ------------  -------------- 
 GB00B9GTXM62   1937399          1937399          2899184         2899184                  4.08 
               ---------------  ---------------  --------------  ----------  -----------  ------------  -------------- 
 
 
 B: Qualifying Financial Instruments 
 Resulting situation after the triggering transaction 
 Type of            Expiration     Exercise/                        Number of voting           % of voting 
 financial           date (xiii)    Conversion Period                rights that may            rights 
 instrument                         (xiv)                            be 
                                                                     acquired if the 
                                                                     instrument is 
                                                                     exercised/ converted. 
                   -------------  -------------------------------  -------------------------  ------------------------ 
 
 
 C: Financial Instruments with similar economic effect to Qualifying Financial 
  Instruments (xv, xvi) 
 Resulting situation after the triggering transaction 
 Type of          Exercise       Expiration     Exercise/         Number of voting           % of voting rights 
 financial         price         date (xvii)    Conversion         rights instrument          (xix, xx) 
 instrument                                     period             refers to 
                                                (xviii) 
                 -------------  -------------  ----------------  -------------------------  -------------------------- 
                                                                                             Nominal       Delta 
                 -------------  -------------  ----------------  -------------------------  ------------  ------------ 
 
 
 Total (A+B+C) 
 Number of voting rights                            Percentage of voting rights 
                                                   ------------------------------------------------------------------- 
 2899184                                            4.08 
                                                   ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the voting rights and/or 
  the 
  financial instruments are effectively held, if applicable: (xxi) 
 
 
 Proxy Voting: 
 10. Name of the proxy holder: 
 
 11. Number of voting rights proxy holder will 
  cease 
  to hold: 
 
 12. Date on which proxy holder will cease to 
  hold 
  voting rights: 
 
 
 
  13. Additional information: 
 14. Contact name: 
                                                                             ---- 
 15. Contact telephone number: 
                                                                             ----

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUVAORWRARRAA

(END) Dow Jones Newswires

October 05, 2018 09:16 ET (13:16 GMT)

Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Silence Therapeutics Charts.
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Silence Therapeutics Charts.